First Gen vs Latest Generation
Reviewed by Dr Lucy NewtonSaxenda (liraglutide) was the first GLP-1 for weight loss but requires daily injections. Zepbound is newer, more effective, and only weekly.
Many users have switched from Saxenda to newer options. See what they say about the transition.
Side-by-side comparison based on 10,000+ Reddit discussions
| Feature | Saxenda | Zepbound | Source Notes |
|---|---|---|---|
| Active Ingredient | Liraglutide | Tirzepatide | Daily GLP-1 vs Weekly Dual-Agonist |
| Typical Weight Loss | ~8% | 20.2% | Zepbound is ~2.5x more effective |
| Dosing Frequency | Daily Injection | Weekly Injection | Convenience factor |
| 2026 List Price | $1,349/mo | $1,060/mo | Novo list price alignment with Wegovy |
| Compounded Cost | $150-$300/mo | $250-$450/mo | Generic liraglutide is cheaper |
| FDA Generation | First-Gen (2014) | Next-Gen (2023) | Technology difference |
| Supply Priority | Low | High | Novo Nordisk de-prioritizing Saxenda |
| Best For | Maintenance | Significant Weight Loss | Based on efficacy clinical trials |
Daily GLP-1 vs Weekly Dual-Agonist
Zepbound is ~2.5x more effective
Convenience factor
Novo list price alignment with Wegovy
Generic liraglutide is cheaper
Technology difference
Novo Nordisk de-prioritizing Saxenda
Based on efficacy clinical trials
Data from the SCALE vs SURMOUNT (Novo Nordisk / Eli Lilly Data)
Comparing Saxenda (liraglutide) and Zepbound (tirzepatide) highlights the evolution of GLP-1 therapy. Saxenda, a first-generation medication, requires daily injections and targets one receptor. Zepbound, the latest generation, requires weekly injections and targets two receptors (GIP and GLP-1).
| Comparison Metric | Saxenda | Zepbound |
|---|---|---|
| Injection Frequency | Daily | Weekly |
| Avg. Weight Loss (%) | ~8% | 20.2% |
| Lost >10% Body Weight | 33% | 83%+ |
| Mechanism | First-Gen GLP-1 | Next-Gen Dual Agonist |
| Supply Priority | Low (De-prioritized) | High (Primary Focus) |
"Clinical evidence and market trends show Zepbound is significantly more effective and convenient than Saxenda. While Saxenda was a pioneer, Zepbound's dual-action mechanism and weekly dosing make it the superior choice for most weight loss patients in 2026."
Results were statistically significant (p < 0.001) across all primary endpoints.
Latest verification performed January 2026.
Answer these 3 questions to see your best match:
Take our 90-second quiz for personalized provider recommendations ranked by your insurance + budget.
Start QuizBased on 9,778+ Reddit posts mentioning side effects
Based on 0+ tips from Reddit users
Compare verified telehealth providers offering these medications
Not sure which provider to choose? Read our in-depth reviews.
Read Provider ReviewsReal questions from Saxenda users
Based on real Reddit discussions from Saxenda users
Not sure which is right for you?
🎯Take Our 2-Minute Quiz